| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Grund Nicholas is a Chief Commercial Officer at AKBA. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $403K at current prices.
Grund Nicholas's largest disclosed position is in AKBA as Chief Commercial Officer, worth about $403K. The recent filings there lean toward selling, a net 55,621 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | Chief Commercial Officer | Sell | 55,621 | $2.10 | $116,804.10 | -11.2% | +10.4% | -33.5% |